Loading
Insider filings for Stemcells Inc are scarce in the SEC (Form 4) feed, the latest one published on 28 January 2016. This page will fill in as new trades are disclosed. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
FY ended December 2025 · cache
15 of 15 declarations
Stemcells Inc is a company focused on the research and development of therapies based on stem cells. It is listed on the NASDAQ under the symbol STEM.
Purchases our model currently ranks for the recommendations list.
All recommendations